Description

Cagrisema Pre-Filled Pen — Combined GLP-1 and Amylin Receptor Research Formulation

Formulation Overview

The Cagrisema Pre-Filled Pen is a dual-pathway research peptide formulation that combines a GLP-1 (glucagon-like peptide-1) receptor agonist with a long-acting amylin analogue in a single, sterile, ready-to-use pre-filled pen. This convenient format eliminates the need for reconstitution, vial handling, and dose preparation — reducing the variables involved in multi-component peptide studies.

The GLP-1 component targets the incretin signalling pathway associated with appetite regulation, gastric function, and glucose-dependent hormone secretion. The amylin component provides complementary satiety signalling through the amylin receptor system. Together, these two pathways engage overlapping but distinct receptor populations and signalling cascades.

Dual-Mechanism Research Rationale

• GLP-1 Pathway: Acts primarily through GLP-1 receptors in the hypothalamus, vagal afferents, and pancreatic islets — influencing appetite signalling, gastric function, and insulinotropic hormone release.
• Amylin Pathway: Acts through amylin receptors (AMYR1-3) concentrated in the area postrema and brainstem — providing central satiety signalling complementary to GLP-1’s effects.
• Combined Research Value: Studying these two pathways simultaneously enables investigation of how incretin and amylin signalling integrate at central and peripheral levels.

Product Description

The pre-filled pen contains a sterile solution of the Cagrisema dual-peptide formulation, pre-measured for consistent dosing in research protocols. The pen format provides ease of use while maintaining sterility throughout repeated use when stored according to instructions.

Each pen is manufactured under controlled conditions with quality verification of both peptide components.

Product Specifications

• Formulation: GLP-1 Receptor Agonist + Long-Acting Amylin Analogue
• Format: Pre-filled, sterile, ready-to-use pen
• Presentation: Sterile solution for injection
• Quality: Manufactured under controlled conditions with quality verification
• Storage: 2-8°C (refrigerated). Protect from light.
• Handling: Pre-filled pen designed for direct use — no reconstitution required

Key Research Benefits

• GLP-1 + Amylin Combination: Combines GLP-1 receptor agonism with a long-acting amylin analogue for dual-pathway appetite research.
• Ready-to-Use Format: Sterile, pre-measured solution — no reconstitution required.
• Central + Peripheral Signalling: Hypothalamic/vagal GLP-1 pathways and brainstem amylin pathways studied together.
• Satiety Mechanism Research: Ideal for investigating how incretin and amylin signals integrate in appetite and gastric function.

How to Use (Research Application)

For experienced laboratory personnel only. This product is a sterile, ready-to-use pre-filled pen for research applications — no reconstitution required.

• Remove the pen from refrigeration and allow it to reach room temperature before use.
• Select the required dose on the pen dial as defined in your research protocol.
• Use sterile technique and attach a fresh needle for each administration.
• Rotate administration sites according to your research protocol.
• Store the pen at 2–8°C when not in use. Do not freeze. Dispose of used needles safely.

Important Notice

This product is for research and laboratory purposes only. Not for human or veterinary consumption. Not for medical use. Not evaluated by SAHPRA. For experienced researchers only. Information is educational reference. Researchers must comply with all applicable laws and guidelines.